🇺🇸 FDA
Patent

US 10821103

Substituted pyridinone-containing trycyclic compounds, and methods using same

granted A61KA61K31/4375A61K31/444

Quick answer

US patent 10821103 (Substituted pyridinone-containing trycyclic compounds, and methods using same) held by ARBUTUS BIOPHARMA CORPORATION expires Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARBUTUS BIOPHARMA CORPORATION
Grant date
Tue Nov 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
58
CPC classes
A61K, A61K31/4375, A61K31/444, A61K31/495, A61K31/506